MedTrace Logo

Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy.

NCT04675840 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-12-13

No results posted yet for this study

Summary

Is there any difference in the intensity of postoperative pain, nausea, urinary retention and legth of hospital stay in patients undergoing robotic assisted laparoscopic surgery if they receive intrathecal morphine or peroral and intravenous opiates during the surgery and is there a significant difference in the need of opiates after the surgery.

Conditions

  • Opioid-Related Disorders

Interventions

PROCEDURE

Robotic-assisted hysterectomy

Robotic-assisted surgery

Sponsors & Collaborators

  • Karlstad Central Hospital

    lead OTHER

Principal Investigators

  • Ragnar N Henningsson, Associate Professor · Dpt of Anesthesiology & Intensive Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2022-06-01
Completion
2022-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04675840 on ClinicalTrials.gov